Computer‐Assisted Sperm Analysis (CASA) Versus Manual Evaluation and the Clinical Significance of Sperm Hyperactivated Motility
Andrology · 2026-07 · 14 (5) · 1401-1412
DOI: 10.1111/andr.70242 ↗At a glance
Vergleichsstudie in Andrology, published online on 2026-04-21. Written by Maria Emanuela Ragosta and 8 co-authors. Institution: Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy. Major MEDLINE topics: Sperm Motility, Semen Analysis, Infertility, Male, Spermatozoa. Cited 1 times so far (Crossref); 24 references. The full text is freely available (open access, CC BY 4.0). Funded by: Italian Ministry of University.
Abstract (original language)
Background
Semen analysis remains the first‐line diagnostic test for male infertility, although it is affected by operator subjectivity. Computer‐assisted sperm analysis (CASA) is proposed to improve objectivity; however, its accuracy and clinical relevance remain uncertain.
Objectives
We evaluated 424 samples from men attending routine semen analysis and 179 samples from male partners of ICSI couples to compare manual assessment with a CASA system (Ceros II), and to explore whether CASA‐derived kinematic parameters, in particular hyperactivated motility (HA), predict ICSI outcomes. Materials and Methods Manual (according to WHO manual) and CASA assessments were compared using correlation analysis, Passing–Bablok regression, and Bland–Altman plots; kinematic parameters were evaluated in relation to ICSI outcomes.
Results
Significant correlations were found between CASA and manual assessment for rapid progressive motility and for sperm count for samples with less than 50 × 10 6 /mL spermatozoa, whereas agreement was lost above this value, unless dilution was performed. Among CASA kinematic parameters, HA measured in whole semen was significantly higher in cycles achieving clinical pregnancy and resulted an independent pregnancy predictor also after adjustment for female age and female factor, showing good discriminative performance.
Discussion
These findings suggest that CASA provides objective, reproducible assessment of sperm motility, and that hyperactivated motility may serve as a clinically relevant marker to improve prediction of ICSI outcomes.
Conclusions
CASA may provide useful support for routine semen analysis and identify clinically meaningful kinematic parameters. Trial Registration Not applicable
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
- IVIRMA Global Research Alliance, Demetra, Florence, Italy.
- Andrology and Gender Endocrinology Unit, Center for Prevention, Diagnosis and Treatment of Infertility, Careggi University Hospital, Florence, Italy.
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
ORCID profiles: Linda Vignozzi, Sara Marchiani
Funding
- Italian Ministry of University
Cite
APA
Ragosta, M. E., Traini, G., Benini, F., Montereggi, M., Bini, F., Tamburrino, L., Vignozzi, L., Baldi, E., & Marchiani, S. (2026). Computer‐Assisted Sperm Analysis (CASA) Versus Manual Evaluation and the Clinical Significance of Sperm Hyperactivated Motility. Andrology, 14(5), 1401-1412. https://doi.org/10.1111/andr.70242
Vancouver
Ragosta ME, Traini G, Benini F, Montereggi M, Bini F, Tamburrino L, et al. Computer‐Assisted Sperm Analysis (CASA) Versus Manual Evaluation and the Clinical Significance of Sperm Hyperactivated Motility. Andrology. 2026;14(5):1401-1412. doi:10.1111/andr.70242
BibTeX
@article{Ragosta2026,
author = {Ragosta, Maria Emanuela and Traini, Giulia and Benini, Francesca and Montereggi, Margherita and Bini, Federica and Tamburrino, Lara and Vignozzi, Linda and Baldi, Elisabetta and Marchiani, Sara},
title = {Computer‐Assisted Sperm Analysis (CASA) Versus Manual Evaluation and the Clinical Significance of Sperm Hyperactivated Motility},
journal = {Andrology},
year = {2026},
volume = {14},
number = {5},
pages = {1401--1412},
doi = {10.1111/andr.70242}
}
EUVIMED